Mankind Pharma to acquire 70% stake in Armed Cell Therapeutics for EUR 48 million EP News Bureau Oct 16, 2026 The deal will give Mankind Pharma access to a pipeline of CAR-T therapies for cancer, including programmes targeting non-Hodgkin…
